369 related articles for article (PubMed ID: 19345227)
1. Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.
Wang H; Kohr MJ; Traynham CJ; Ziolo MT
J Mol Cell Cardiol; 2009 Aug; 47(2):304-14. PubMed ID: 19345227
[TBL] [Abstract][Full Text] [Related]
2. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
3. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current.
Wang H; Kohr MJ; Wheeler DG; Ziolo MT
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1473-80. PubMed ID: 18203845
[TBL] [Abstract][Full Text] [Related]
5. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
Nagayama T; Zhang M; Hsu S; Takimoto E; Kass DA
J Pharmacol Exp Ther; 2008 Aug; 326(2):380-7. PubMed ID: 18456872
[TBL] [Abstract][Full Text] [Related]
6. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes.
Ziolo MT; Lewandowski SJ; Smith JM; Romano FD; Wahler GM
Br J Pharmacol; 2003 Mar; 138(5):986-94. PubMed ID: 12642401
[TBL] [Abstract][Full Text] [Related]
8. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling.
Cawley SM; Kolodziej S; Ichinose F; Brouckaert P; Buys ES; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H157-63. PubMed ID: 21536853
[TBL] [Abstract][Full Text] [Related]
9. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
Lee DI; Vahebi S; Tocchetti CG; Barouch LA; Solaro RJ; Takimoto E; Kass DA
Basic Res Cardiol; 2010 May; 105(3):337-47. PubMed ID: 20107996
[TBL] [Abstract][Full Text] [Related]
10. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
11. Preservation of nitric oxide-induced relaxation of porcine coronary artery: roles of the dimers of soluble guanylyl cyclase, phosphodiesterase type 5, and cGMP-dependent protein kinase.
Liu J; Chen Z; Ye L; Liu H; Dou D; Liu L; Yu X; Gao Y
Pflugers Arch; 2014 Oct; 466(10):1999-2008. PubMed ID: 24413911
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
[TBL] [Abstract][Full Text] [Related]
13. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
Hussain MB; Hobbs AJ; MacAllister RJ
Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
[TBL] [Abstract][Full Text] [Related]
14. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
15. Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice.
Schröder F; Klein G; Fiedler B; Bastein M; Schnasse N; Hillmer A; Ames S; Gambaryan S; Drexler H; Walter U; Lohmann SM; Wollert KC
Cardiovasc Res; 2003 Nov; 60(2):268-77. PubMed ID: 14613856
[TBL] [Abstract][Full Text] [Related]
16. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.
Frigolet ME; Thomas G; Beard K; Lu H; Liu L; Fantus IG
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E321-E334. PubMed ID: 28679626
[TBL] [Abstract][Full Text] [Related]
17. Activation of the nitric oxide-cGMP pathway reduces phasic contractions in neonatal rat bladder strips via protein kinase G.
Artim DE; Kullmann FA; Daugherty SL; Wu HY; de Groat WC
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F333-40. PubMed ID: 19493964
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes.
Su J; Scholz PM; Weiss HR
Exp Biol Med (Maywood); 2005 Apr; 230(4):242-50. PubMed ID: 15792945
[TBL] [Abstract][Full Text] [Related]
19. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
Murthy KS
Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
[TBL] [Abstract][Full Text] [Related]
20. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]